Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts
Discover trends, market shifts, and competitive outlooks for the ribose-nucleic acid (rna)-based therapeutics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What is the Projected CAGR for the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Size from 2025 to 2034?
The market for ribose-nucleic acid (RNA)-based therapeutics has experienced considerable growth in the past few years. It is projected to increase from $15.79 billion in 2024 to $17.26 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.3%. The development seen historically can be credited to factors such as increased investments and funding, the uncovering of RNA interference (RNAi), favorable outcomes in clinical trials of antisense oligonucleotides (ASOs), supportive regulatory provisions and frameworks, as well as collaborations and partnerships.
The market for ribose-nucleic acid (RNA)-based therapeutics is projected to witness robust growth in the coming years. The market size is forecasted to reach $24.26 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.9%. Factors contributing to this growth during the forecast period include extended usage of these therapeutics, increasing market demand and acceptance, supportive regulatory frameworks, the incorporation of AI and machine learning, and its emerging usage in treating rare diseases. Foreseen trends during this period involve the development of advanced delivery systems, RNA therapeutics targeting multiple areas, personalized RNA therapies, regulatory breakthroughs, and the commercialization and growth of the market.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18454&type=smp
Which Primay Drivers Are Accelerating Growth in the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
The escalating incidence of cancer is projected to stimulate the expansion of the ribose-nucleic acid (RNA)-based therapeutics market in the near future. Cancer encompasses a disease state characterized by uncontrolled and abnormal cell growth which can result in death if not treated. Factors such as the aged population, lifestyle alterations, heightened exposure to risks, and superior detection methods contribute to its prevalence. RNA-based therapeutics signify a hopeful prospect for cancer therapy by directly impacting its genetic and molecular underpinnings. For example, the Australian Institute of Health and Welfare, an Australian government health administration, reported in August 2023 that roughly 151,000 individuals were diagnosed with cancer (excluding basal cell carcinomas (BCC) and squamous cell carcinomas (SCC) of the skin) in 2021, and this figure is projected to climb to 185,000 by 2030. Consequently, the rising prevalence of cancer is fuelling the growth of the ribose-nucleic acid (RNA)-based therapeutics market.
What Segment Types Define the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Structure?
The ribose-nucleic acid (RNA)-based therapeutics market covered in this report is segmented –
1) By Type: RNA Interference (RNAi), RNA Antisense
2) By Technology: Enabling Technology, Enabled Technology
3) By Therapeutic Area: Oncology, Genetic Disorder, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Other Therapeutic Areas
4) By End User: Research Institutes, Hospitals And Clinics
Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), MicroRNA (miRNA)
2) By RNA Antisense: Antisense Oligonucleotides (ASOs), Antisense RNA
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=18454&type=smp
Which Regions Are Key Players in the Growth of the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
North America was the largest region in the ribose-nucleic acid (RNA)-based therapeutics market in 2024. The regions covered in the ribose-nucleic acid (RNA)-based therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Over the Coming Years?
Major businesses in the ribose nucleic acid (RNA)-based therapeutics market are concentrating their efforts on creating advanced treatments, such as messenger RNA (mRNA)-based booster vaccines. These innovative medical solutions are intended to boost the potency of immunization, address the rise of new viral strains, and fortify the overall resilience of vaccine-induced immunity. The science behind an mRNA-instigated booster vaccine involves the use of messenger RNA, urging cells to produce a protein that bolsters the body’s defense against specific pathogens. For example, Gennova Biopharmaceuticals Ltd., an enterprise based in India, introduced GEMCOVAC-OM, the nation’s premiere mRNA booster vaccine targeted at the Omicron variant of COVID-19, in June 2023. Given the reduced effectiveness of traditional vaccines against Omicron, this booster plays an indispensable role. Leveraging mRNA technology, GEMCOVAC-OM strengthens immunity and provides superior protection against the mutating virus.
View the full report here:
What Is the Definition of the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
The ribose-nucleic acid (RNA)-based therapeutics refer to a class of medical treatments that utilize ribose-nucleic acid (RNA) molecules to influence cellular processes, typically by targeting specific genetic sequences. These therapies are designed to treat various conditions, including genetic disorders, cancers, and infectious diseases, by modulating gene expression, protein production, or cellular signaling pathways.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18454
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
